Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1225 of 1294 entries
View as:

A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT05379829 Org: User:
Start: 05/30/22 End: 09/02/24 Due: 09/02/25

Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04788511 Org: User:
Start: 03/16/21 End: 04/18/23 Due: 04/18/24

Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments

Phase: N/A Priority: Normal
NCT ID: NCT04809311 Org: User:
Start: 04/30/24 End: 01/07/25 Due: 01/07/26

Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10)

Phase: N/A Priority: Normal
NCT ID: NCT05082116 Org: User:
Start: 09/27/21 End: 12/28/22 Due: 12/28/23

A Study of FT-7051 in Men With MCRPC

Phase: N/A Priority: Normal
NCT ID: NCT04575766 Org: User:
Start: 12/30/20 End: 11/15/22 Due: 11/15/23

Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01831765 Org: User:
Start: 08/26/13 End: 06/11/15 Due: 06/11/16

A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the Body

Phase: N/A Priority: Normal
NCT ID: NCT05564104 Org: User:
Start: 04/05/23 End: 12/19/24 Due: 12/19/25

Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00704574 Org: User:
Start: 01/31/08 End: 06/30/10 Due: 06/30/11

A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT02505334 Org: User:
Start: 07/21/15 End: 11/09/17 Due: 11/09/18

Activated Recombinant Human Factor VII in Pelvic-acetabular Fracture Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT01601457 Org: User:
Start: 09/30/02 End: 04/30/04 Due: 04/30/05

An Observational Study on Treatment Compliance by Children Treated With Growth Hormone

Phase: N/A Priority: Normal
NCT ID: NCT01068639 Org: User:
Start: 02/28/10 End: 04/30/10 Due: 04/30/11

Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00728455 Org: User:
Start: 07/31/08 End: 12/31/09 Due: 12/31/10

The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT00503698 Org: User:
Start: 07/31/07 End: 12/31/08 Due: 12/31/09

Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02084810 Org: User:
Start: 03/31/14 End: 07/31/14 Due: 07/31/15

Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide

Phase: N/A Priority: Normal
NCT ID: NCT02231684 Org: User:
Start: 09/30/14 End: 01/31/15 Due: 01/31/16

Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00806936 Org: User:
Start: 12/31/08 End: 12/31/09 Due: 12/31/10

Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins

Phase: N/A Priority: Normal
NCT ID: NCT00657319 Org: User:
Start: 10/31/07 End: 04/30/08 Due: 04/30/09

Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01511159 Org: User:
Start: 10/31/01 End: 12/31/01 Due: 12/31/02

Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent

Phase: N/A Priority: Normal
NCT ID: NCT01511198 Org: User:
Start: 02/28/01 End: 10/31/01 Due: 10/31/02

The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD

Phase: N/A Priority: Normal
NCT ID: NCT00521690 Org: User:
Start: 12/31/06 End: 08/31/07 Due: 08/31/08

The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01536665 Org: User:
Start: 02/29/12 End: 08/31/12 Due: 08/31/13

Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia

Phase: N/A Priority: Normal
NCT ID: NCT01988532 Org: User:
Start: 10/31/13 End: 10/31/14 Due: 10/31/15

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT04082429 Org: User:
Start: 11/13/19 End: 02/21/28 Due: 02/21/29

Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00097877 Org: User:
Start: 01/31/05 End: 11/30/06 Due: 11/30/07

A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin

Phase: N/A Priority: Normal
NCT ID: NCT04770532 Org: User:
Start: 03/05/21 End: 03/01/22 Due: 03/01/23